JP2004522714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004522714A5 JP2004522714A5 JP2002544073A JP2002544073A JP2004522714A5 JP 2004522714 A5 JP2004522714 A5 JP 2004522714A5 JP 2002544073 A JP2002544073 A JP 2002544073A JP 2002544073 A JP2002544073 A JP 2002544073A JP 2004522714 A5 JP2004522714 A5 JP 2004522714A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- methylsulfonyl
- pyrimidin
- fluorophenyl
- isopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 4
- 206010045261 Type IIa hyperlipidaemia Diseases 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims 4
- 108010028554 LDL Cholesterol Proteins 0.000 claims 3
- 159000000007 calcium salts Chemical class 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- RWZYEKXHAQMRIO-UHFFFAOYSA-N 2,2-dihydroxyhept-6-enoic acid Chemical compound OC(=O)C(O)(O)CCCC=C RWZYEKXHAQMRIO-UHFFFAOYSA-N 0.000 claims 1
- 102000005666 Apolipoprotein A-I Human genes 0.000 claims 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 claims 1
- 102000018616 Apolipoproteins B Human genes 0.000 claims 1
- 108010027006 Apolipoproteins B Proteins 0.000 claims 1
- 108010023302 HDL Cholesterol Proteins 0.000 claims 1
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028429.9A GB0028429D0 (en) | 2000-11-22 | 2000-11-22 | Therapy |
| GB0028429.9 | 2000-11-22 | ||
| PCT/GB2001/005041 WO2002041895A1 (en) | 2000-11-22 | 2001-11-16 | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009255813A Division JP2010031047A (ja) | 2000-11-22 | 2009-11-09 | ヘテロ型家族性高コレステロール血症の治療におけるロスバスタチン（ｚｄ−４５２２）の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004522714A JP2004522714A (ja) | 2004-07-29 |
| JP2004522714A5 true JP2004522714A5 (OSRAM) | 2005-12-22 |
| JP5062940B2 JP5062940B2 (ja) | 2012-10-31 |
Family
ID=9903629
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002544073A Expired - Lifetime JP5062940B2 (ja) | 2000-11-22 | 2001-11-16 | ヘテロ型家族性高コレステロール血症の治療におけるロスバスタチン（ｚｄ−４５２２）の使用 |
| JP2009255813A Pending JP2010031047A (ja) | 2000-11-22 | 2009-11-09 | ヘテロ型家族性高コレステロール血症の治療におけるロスバスタチン（ｚｄ−４５２２）の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009255813A Pending JP2010031047A (ja) | 2000-11-22 | 2009-11-09 | ヘテロ型家族性高コレステロール血症の治療におけるロスバスタチン（ｚｄ−４５２２）の使用 |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6858618B2 (OSRAM) |
| EP (1) | EP1339409B1 (OSRAM) |
| JP (2) | JP5062940B2 (OSRAM) |
| KR (1) | KR100815042B1 (OSRAM) |
| CN (1) | CN1268339C (OSRAM) |
| AR (1) | AR031766A1 (OSRAM) |
| AT (1) | ATE394103T1 (OSRAM) |
| AU (2) | AU2002214165B9 (OSRAM) |
| BG (1) | BG66009B1 (OSRAM) |
| BR (1) | BR0115511A (OSRAM) |
| CA (1) | CA2429263C (OSRAM) |
| CY (1) | CY1110428T1 (OSRAM) |
| CZ (1) | CZ301583B6 (OSRAM) |
| DE (1) | DE60133921D1 (OSRAM) |
| DK (1) | DK1339409T3 (OSRAM) |
| EE (1) | EE05507B1 (OSRAM) |
| ES (1) | ES2305118T3 (OSRAM) |
| GB (1) | GB0028429D0 (OSRAM) |
| HU (1) | HUP0301380A3 (OSRAM) |
| IL (2) | IL155919A0 (OSRAM) |
| IS (1) | IS6819A (OSRAM) |
| MX (1) | MXPA03004336A (OSRAM) |
| MY (1) | MY134902A (OSRAM) |
| NO (1) | NO326245B1 (OSRAM) |
| NZ (1) | NZ525754A (OSRAM) |
| PL (1) | PL365386A1 (OSRAM) |
| PT (1) | PT1339409E (OSRAM) |
| RU (1) | RU2294744C2 (OSRAM) |
| SI (1) | SI1339409T1 (OSRAM) |
| SK (1) | SK6212003A3 (OSRAM) |
| TW (1) | TWI238720B (OSRAM) |
| UA (1) | UA75614C2 (OSRAM) |
| WO (1) | WO2002041895A1 (OSRAM) |
| ZA (1) | ZA200303636B (OSRAM) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003305D0 (en) * | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| US7470724B2 (en) * | 2003-04-25 | 2008-12-30 | Gilead Sciences, Inc. | Phosphonate compounds having immuno-modulatory activity |
| US7417055B2 (en) * | 2003-04-25 | 2008-08-26 | Gilead Sciences, Inc. | Kinase inhibitory phosphonate analogs |
| CA2523083C (en) | 2003-04-25 | 2014-07-08 | Gilead Sciences, Inc. | Antiviral phosphonate analogs |
| US7407965B2 (en) * | 2003-04-25 | 2008-08-05 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| US20090247488A1 (en) * | 2003-04-25 | 2009-10-01 | Carina Cannizzaro | Anti-inflammatory phosphonate compounds |
| US7452901B2 (en) * | 2003-04-25 | 2008-11-18 | Gilead Sciences, Inc. | Anti-cancer phosphonate analogs |
| US20050261237A1 (en) * | 2003-04-25 | 2005-11-24 | Boojamra Constantine G | Nucleoside phosphonate analogs |
| US7396927B2 (en) * | 2003-08-28 | 2008-07-08 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| US7432273B2 (en) * | 2003-10-24 | 2008-10-07 | Gilead Sciences, Inc. | Phosphonate analogs of antimetabolites |
| WO2005051921A1 (en) | 2003-11-24 | 2005-06-09 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| PT1689723E (pt) * | 2003-12-02 | 2011-07-06 | Teva Pharma | Padrão referência para a caracterização de rosuvastatina |
| US20070179166A1 (en) * | 2003-12-24 | 2007-08-02 | Valerie Niddam-Hildesheim | Process for preparation of statins with high syn to anti ratio |
| US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| KR20070088324A (ko) * | 2004-05-26 | 2007-08-29 | 케이지케이 시너자이즈 인코포레이티드 | 플라보노이드 및 토코트리에놀을 포함하는 기능성 식품 및그에따른 방법 |
| US7179916B2 (en) * | 2004-07-13 | 2007-02-20 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of rosuvastatin |
| JP2008508291A (ja) | 2004-07-27 | 2008-03-21 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ｈｉｖ剤としてのヌクレオシドホスホネート結合体 |
| US20070037979A1 (en) * | 2005-02-22 | 2007-02-15 | Valerie Niddam-Hildesheim | Preparation of rosuvastatin |
| US20070167625A1 (en) * | 2005-02-22 | 2007-07-19 | Anna Balanov | Preparation of rosuvastatin |
| CA2594017C (en) | 2005-02-22 | 2010-04-20 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| KR20070062996A (ko) * | 2005-08-16 | 2007-06-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | 결정성 로수바스타틴 중간체 |
| US9427437B2 (en) | 2008-01-31 | 2016-08-30 | The Trustees Of The University Of Pennsylvania | Hypercholesterolemia and tendinous injuries |
| US8383614B2 (en) * | 2008-01-31 | 2013-02-26 | The Trustees Of The University Of Pennsylvania | Hypercholestrolemia and tendinous injuries |
| EP2298745B1 (en) | 2008-05-27 | 2014-09-03 | Changzhou Pharmaceutical Factory | Preparation method of rosuvastatin calcium and its intermediates |
| EP2307435B1 (en) | 2008-07-08 | 2012-06-13 | Gilead Sciences, Inc. | Salts of hiv inhibitor compounds |
| IL314360B2 (en) | 2012-09-17 | 2025-09-01 | F Hoffmann La Roche Ltd | Method for the synthesis of thyroid hormone analogs and their polymorphs |
| US9132117B2 (en) | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
| US10600502B2 (en) | 2016-12-20 | 2020-03-24 | Astrazeneca Uk Ltd. | Systems and methods for dispensing a statin medication over the counter |
| EP3661937B1 (en) | 2017-08-01 | 2021-07-28 | Gilead Sciences, Inc. | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections |
| PE20220164A1 (es) | 2019-05-27 | 2022-01-28 | Immatics Us Inc | Vectores viricos y uso de los mismos en terapias celulares adoptivas |
| DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
| US20220008519A1 (en) | 2020-07-09 | 2022-01-13 | Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) | Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho |
| US20220056411A1 (en) | 2020-08-21 | 2022-02-24 | Immatics US, Inc. | Methods for isolating cd8+ selected t cells |
| TW202245775A (zh) * | 2021-02-01 | 2022-12-01 | 美商瑪德瑞高製藥公司 | 用於治療肝病症或脂質病症之瑞舒伐他汀（Ｒｏｓｕｖａｓｔａｔｉｎ）和瑞司美替隆（Ｒｅｓｍｅｔｉｒｏｍ）的治療組合 |
| US12377104B1 (en) | 2024-02-06 | 2025-08-05 | Madrigal Pharmaceuticals, Inc. | Methods for treating a fatty liver disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2051907C1 (ru) * | 1989-05-22 | 1996-01-10 | Сандос АГ | Способ получения 7-замещенной гептен-6-овой кислоты |
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US6369103B1 (en) * | 1994-01-18 | 2002-04-09 | Bristol-Myers Squibb Company | Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| EP1322289B1 (en) * | 2000-09-20 | 2007-07-25 | Jagotec AG | Spray drying process of compositions containing fenofibrate |
-
2000
- 2000-11-22 GB GBGB0028429.9A patent/GB0028429D0/en not_active Ceased
-
2001
- 2001-11-16 NZ NZ525754A patent/NZ525754A/en not_active IP Right Cessation
- 2001-11-16 MX MXPA03004336A patent/MXPA03004336A/es unknown
- 2001-11-16 PL PL01365386A patent/PL365386A1/xx not_active Application Discontinuation
- 2001-11-16 UA UA2003054394A patent/UA75614C2/uk unknown
- 2001-11-16 RU RU2003114300/15A patent/RU2294744C2/ru not_active IP Right Cessation
- 2001-11-16 EE EEP200300239A patent/EE05507B1/xx not_active IP Right Cessation
- 2001-11-16 WO PCT/GB2001/005041 patent/WO2002041895A1/en not_active Ceased
- 2001-11-16 CA CA002429263A patent/CA2429263C/en not_active Expired - Fee Related
- 2001-11-16 AT AT01982623T patent/ATE394103T1/de active
- 2001-11-16 HU HU0301380A patent/HUP0301380A3/hu not_active Application Discontinuation
- 2001-11-16 PT PT01982623T patent/PT1339409E/pt unknown
- 2001-11-16 ES ES01982623T patent/ES2305118T3/es not_active Expired - Lifetime
- 2001-11-16 AU AU2002214165A patent/AU2002214165B9/en not_active Revoked
- 2001-11-16 AU AU1416502A patent/AU1416502A/xx active Pending
- 2001-11-16 DE DE60133921T patent/DE60133921D1/de not_active Expired - Lifetime
- 2001-11-16 EP EP01982623A patent/EP1339409B1/en not_active Revoked
- 2001-11-16 US US10/432,402 patent/US6858618B2/en not_active Expired - Lifetime
- 2001-11-16 IL IL15591901A patent/IL155919A0/xx unknown
- 2001-11-16 DK DK01982623T patent/DK1339409T3/da active
- 2001-11-16 CN CNB018221599A patent/CN1268339C/zh not_active Expired - Lifetime
- 2001-11-16 CZ CZ20031406A patent/CZ301583B6/cs not_active IP Right Cessation
- 2001-11-16 KR KR1020037006791A patent/KR100815042B1/ko not_active Ceased
- 2001-11-16 SK SK621-2003A patent/SK6212003A3/sk not_active Application Discontinuation
- 2001-11-16 JP JP2002544073A patent/JP5062940B2/ja not_active Expired - Lifetime
- 2001-11-16 BR BR0115511-3A patent/BR0115511A/pt not_active Application Discontinuation
- 2001-11-16 SI SI200130839T patent/SI1339409T1/sl unknown
- 2001-11-20 MY MYPI20015303A patent/MY134902A/en unknown
- 2001-11-21 TW TW090128858A patent/TWI238720B/zh not_active IP Right Cessation
- 2001-11-22 AR ARP010105452A patent/AR031766A1/es unknown
-
2003
- 2003-05-12 ZA ZA200303636A patent/ZA200303636B/en unknown
- 2003-05-13 BG BG107811A patent/BG66009B1/bg unknown
- 2003-05-14 IL IL155919A patent/IL155919A/en unknown
- 2003-05-19 IS IS6819A patent/IS6819A/is unknown
- 2003-05-21 NO NO20032292A patent/NO326245B1/no not_active IP Right Cessation
-
2008
- 2008-07-07 CY CY20081100703T patent/CY1110428T1/el unknown
-
2009
- 2009-11-09 JP JP2009255813A patent/JP2010031047A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004522714A5 (OSRAM) | ||
| JP2022009125A5 (OSRAM) | ||
| RU2003114300A (ru) | Применение розувастатина (zd-4522) в лечении гетерозиготной семейной гиперхолестеринемии | |
| JP2011500851A5 (OSRAM) | ||
| JP2005515966A5 (OSRAM) | ||
| JP2005520778A5 (OSRAM) | ||
| JP6068765B2 (ja) | 薬学的複合製剤 | |
| JP2006518731A5 (OSRAM) | ||
| JP2005508963A5 (OSRAM) | ||
| AU2025203515A1 (en) | Methods for Treating Obstructive Sleep Apnea | |
| JP2004519424A5 (ja) | インシュリン分泌促進剤およびＨＭＧ−Ｃｏ−Ａレダクターゼ阻害剤およびＡＣＥ阻害剤から選択される活性成分を含む組み合わせ | |
| JP2005512946A5 (OSRAM) | ||
| JP2013536206A5 (OSRAM) | ||
| JP2002530353A5 (OSRAM) | ||
| EP2197439A2 (en) | Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid | |
| RU2013112890A (ru) | Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина | |
| JP2003534282A5 (OSRAM) | ||
| JP2002536333A5 (OSRAM) | ||
| JP2009539877A5 (OSRAM) | ||
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| JP2002536333A (ja) | コレステロール低下薬の使用 | |
| TW200951117A (en) | Combination of dronedarone with at least one diuretic, therapeutic application thereof | |
| DE60019968D1 (de) | Verwendung von gepirone metabolite zur erstellungs eines medicaments zur behandlung von neurologischer krankheiten | |
| EP1203585B1 (en) | Anti-ischemic agent | |
| TW200529818A (en) | Hypocholesterolemic comositions |